ImmunityBio Inc (IBRX)
8.17
+0.11
(+1.36%)
USD |
NASDAQ |
May 10, 11:31
ImmunityBio Profit Margin (Quarterly): -167.9K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -167.9K% |
| September 30, 2023 | -116.6K% |
| June 30, 2023 | -336.3K% |
| March 31, 2023 | -32.32K% |
| December 31, 2022 | -148.2K% |
| September 30, 2022 | -94.02K% |
| June 30, 2022 | -270.3K% |
| March 31, 2022 | -734.5K% |
| Date | Value |
|---|---|
| December 31, 2021 | -23.40K% |
| September 30, 2021 | -132.8K% |
| June 30, 2021 | -26.04K% |
| March 31, 2021 | -57.28K% |
| December 31, 2020 | |
| September 30, 2020 | -43.45K% |
| June 30, 2020 | -11.80K% |
| March 31, 2020 | -22.45K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-734.5K%
Minimum
Mar 2022
-11.80K%
Maximum
Jun 2020
-147.8K%
Average
-94.02K%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -150.8% |
| Return on Invested Capital | -327.4% |
| Operating Margin (Quarterly) | -60.79K% |
| Return on Net Operating Assets | -253.5% |